About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Impact of Telemonitoring in the Management of Hypertension

NCT04607239·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Semir NOUIRA, Prof
CONTACT
0021673106085 semir.nouira@rns.tn
Sonia BEN HAFAIEDH, MD
CONTACT
0021698709311 s.hafaiedh@medis.com.tn

Lead

Les Laboratoires des Médicaments Stériles

Age

35–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Included are patients with:
age ≥ 35 years old
newly diagnosed hypertention
uncontrolled hypertention

You may not be if

Excluded are patients with:
orthostatic hypotension
chronic renal failure (serum creatinine \> 200 micromol / L)
acute coronary syndrome
coronary revascularization or stroke within the past 3 months
known secondary causes of hypertension
pregnancy
New York Heart Association Class III or IV heart failure or left ventricular ejection fraction \< 30%
dementia or another cause that prevents the application of remote monitoring

The record

StatusUnknown

PhaseNo phase

Taking part460

StartedJul 2020

UpdatedNov 24, 2020

Conditions

Health Services Administration Telemedicine Hypertension

Where1

Fattouma Bourguiba Hospital
Monastir, Tunisia

Clareo Health | The Impact of Telemonitoring in the Management of Hypertension